Valuation : GlaxoSmithKline plc

Market Cap 72.27B 97.89B 84.23B 79.31B 135B 9,315B 136B 940B 363B 4,745B 368B 360B 15,033B P/E 2026 *
13.8x
P/E 2027 * 11.3x
Enterprise Value 92.99B 126B 108B 102B 174B 11,986B 175B 1,210B 467B 6,106B 473B 463B 19,344B EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.54x
Free-Float
92.75%
Yield 2026 *
3.86%
Yield 2027 * 4.16%
Manager TitleAgeSince
Chief Executive Officer 52 2025-12-31
Director of Finance/CFO 64 2023-04-30
Compliance Officer - 2018-07-31
Director TitleAgeSince
Director/Board Member 52 2026-05-05
Director/Board Member 64 2017-12-31
Chairman 67 2019-08-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 649B
+0.86%-4.13%+19.24%+68.37% 440B
-0.80%-0.43%+28.92%+35.45% 346B
-0.13%-14.97%+9.41%+26.71% 263B
-1.90%-2.72%-2.72%+7.41% 250B
-0.48%-11.65%+39.75%+50.82% 213B
-1.06%-4.23%-14.70%-57.36% 201B
-0.68%-2.65%+25.82%+91.64% 182B
Average -0.57%-4.42%+22.94%+42.34% 393.74B
Weighted average by Cap. -0.42%-3.88%+31.98%+57.01%

Financials

2026 *2027 *
Net sales 33.95B 45.98B 39.57B 37.26B 63.52B 4,376B 63.77B 442B 171B 2,229B 173B 169B 7,062B 35.49B 48.07B 41.37B 38.95B 66.4B 4,575B 66.67B 462B 178B 2,330B 181B 177B 7,383B
Net income 5.38B 7.29B 6.27B 5.91B 10.07B 693B 10.11B 69.99B 27.05B 353B 27.37B 26.77B 1,119B 6.37B 8.63B 7.43B 7B 11.93B 822B 11.97B 82.91B 32.04B 419B 32.42B 31.72B 1,326B
Net Debt 20.72B 28.07B 24.15B 22.74B 38.77B 2,671B 38.93B 270B 104B 1,361B 105B 103B 4,311B 17.99B 24.36B 20.96B 19.74B 33.65B 2,318B 33.79B 234B 90.42B 1,181B 91.48B 89.49B 3,741B
Logo GlaxoSmithKline plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!